Approval · Notice of Compliance 5010 · 1995
DIDROCAL: Notice of Compliance 5010
Issued July 19, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5010
- Date
- July 19, 1995
- Company
- Procter & Gamble Pharmaceuticals Canada, IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIDROCAL | 02176017 | Cancelled Post Market |
Medicinal ingredients
- ETIDRONATE DISODIUM 400 MG per TAB
- CALCIUM CARBONATE 500 MG per TAB